Paramount stock rises after FCC approves Skydance merger
LONDON - EDX Medical (TASE:BLWV) Group plc (AQSE:EDX) announced Thursday that shareholders approved both resolutions proposed at its General Meeting held in London.
The meeting, which took place at the Heritage Centre in Westminster, saw shareholders vote on two key resolutions related to the directors’ authority to allot securities. According to the company statement, the first resolution, which authorizes directors to allot securities within limits outlined in the meeting notice, passed with 94.55% approval. The second resolution, allowing directors to allot equity securities for cash as if section 561 of the Companies Act 2006 did not apply, also passed with the same percentage of votes.
The poll results showed 181,853,678 votes in favor and 10,491,190 against both resolutions, with 33,089 votes withheld in each case. The company noted that votes withheld are not counted as votes in law and were not included in calculating the proportion of votes for and against the resolutions.
EDX Medical, which is listed on the Apex Segment of the AQSE Growth Market, had 372,308,871 ordinary shares in issue as of July 3. The company operates diagnostic facilities in Cambridge and Oxford and maintains strategic partnerships with organizations including Thermo Fisher (NYSE:TMO) EMEA Ltd.
The full text of each resolution is available in the Notice of General Meeting published on the company’s website, according to the press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.